Nature Medicine, Published online: 09 July 2026; doi:10.1038/s41591-026-04490-8
The 2024 revision of the McDonald diagnostic criteria is an important step toward earlier and more inclusive diagnosis of multiple sclerosis. Realizing its full potential will require continued refinement of biomarkers, disease stratification and clinical trial approaches.
